Parathyroid Sestamibi
- Sestamibi parathyroid imaging is a hunt for an enlarged parathyroid gland in someone with primary hyperparathyroidism — usually a single adenoma the surgeon wants to find before cutting.
- The trick is differential washout: the tracer leaves normal thyroid faster than it leaves a hyperfunctioning parathyroid, so the adenoma is the spot that's still glowing on the late images.
- Two common ways to do it — dual-phase (early vs. delayed) and dual-tracer (subtract a thyroid-only agent) — and adding SPECT/CT pins the gland in 3D for the surgeon.
- It's a localizing study, not a diagnosing one: the lab values make the diagnosis, and the scan just tells you where to dig.
Imagine you've already proven there's a thief in the house — the bloodwork is unambiguous, calcium is high, parathyroid hormone is inappropriately high — and now you just need to know which room the thief is hiding in before you kick the door down. That's parathyroid sestamibi imaging in one sentence. The diagnosis is already made; this scan is the floor plan.
Why we even do this
The four parathyroid glands are tiny — roughly rice-grain sized — and they sit behind the thyroid, sometimes in slightly rogue locations (down in the chest, tucked behind the esophagus, hiding inside the thyroid itself). In primary hyperparathyroidism, usually one of them grows into an overachieving adenoma that pumps out hormone nobody asked for.
Surgeons love a map. If you can point to a single bad gland beforehand, the surgeon can do a small, targeted operation instead of exploring all four glands and rummaging around the neck. So the whole point of the scan is localization — not "is something wrong" but "where is it."
This is a localizing study, full stop. A negative scan does not rule out hyperparathyroidism — plenty of real adenomas are too small or too shy to show up. The biochemistry diagnoses the disease; imaging just helps find the culprit. (The complementary ultrasound side of this lives over in parathyroid imaging.)
The tracer trick: differential washout
The workhorse tracer is technetium-99m sestamibi (the radiologists abbreviate it Tc-99m MIBI). It's a little radioactive molecule that gets sucked into cells that are metabolically busy — specifically, cells stuffed with mitochondria. Hyperfunctioning parathyroid adenomas are packed with mitochondria, like a tiny factory running three shifts.
Here's the clever part. Sestamibi is taken up by both the thyroid and an overactive parathyroid. On its own, that's useless — they're sitting right on top of each other. But the tracer washes out of the thyroid faster than it washes out of the adenoma. So if you image early and again later, the thyroid fades while the adenoma stubbornly keeps glowing.
Think of two sponges in the sun. Both start soaking wet (early images, everything lights up). Come back a couple hours later and the normal thyroid sponge has dried out, while the adenoma sponge is still damp. That persistent damp spot is your answer.
The adenoma is the focus that retains tracer on the delayed images after the thyroid has washed out. You're looking for what stays bright, not just what's bright.
Two ways to run the study
There are two classic protocols, and they're solving the same problem — separating thyroid from parathyroid — from opposite directions.
| Protocol | How it works | The catch |
|---|---|---|
| Dual-phase (single-tracer) | One injection of sestamibi; image early and delayed, look for the focus that retains tracer. | Adenomas with fast washout can vanish by the delayed images. |
| Dual-tracer (subtraction) | Sestamibi lights up thyroid + parathyroid; a thyroid-only agent (iodine-123 or pertechnetate) lights up just thyroid. Subtract one from the other and what's left is parathyroid. | More moving parts; patient motion between images smears the subtraction. |
Many shops run a hybrid of these. The "right" protocol is genuinely institution-dependent, so don't memorize one as gospel.
SPECT/CT: turning a glow into an address
Planar (flat) images tell you that there's a hot spot but are lousy at depth — is that gland in front of the trachea or behind it? Down in the chest? Single-photon emission CT fused with a CT (SPECT/CT) solves this by giving the glowing spot real anatomic coordinates. For ectopic glands hiding in weird places, it's the difference between "somewhere in the neck" and "right there, 2 cm behind the upper esophagus." If you want the nuts and bolts of how that camera works, see gamma camera and SPECT.
The traps
Sestamibi is not parathyroid-specific. Thyroid nodules and thyroid cancer can also retain tracer and masquerade as an adenoma — this is one reason the dual-tracer subtraction (or a correlating ultrasound) earns its keep. A "hot" focus that's actually inside a thyroid nodule has fooled many a reader.
Multigland disease (hyperplasia, or the multiple adenomas you'd worry about in familial syndromes) is the scan's weak spot. Sestamibi is great at finding one loud adenoma and notoriously worse when several glands are mildly overactive — the contrast trick that makes a single gland pop just doesn't work as well when there's no quiet background to compare against.
So: high calcium, high parathyroid hormone, and a surgeon who wants a target. Sestamibi exploits the fact that the bad gland clings to its tracer longer than the thyroid does, SPECT/CT turns that glow into a surgical address, and you stay humble about the small and the multiple. The lab made the diagnosis — your job was just to draw the map. While you're in the neighborhood, the thyroid's own scan story is worth a look over in thyroid scintigraphy.